T. Roskams

Hepatology · 2004–2012

A researcher in the Science corpus: 8 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom T. Roskams trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Llovet
  2. Jordi Bruix1 , 2

Who trusts T. Roskams overall

  1. J. Dowman
  2. Sumera I. Ilyas

Papers from T. Roskams's perspective

Ordered by how strongly the researchers T. Roskams trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
  2. Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial (Annals of Surgery)
  3. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. (Journal of the American College of Surgeons)
  4. Novel advancements in the management of hepatocellular carcinoma in 2008. (Journal of Hepatology)
  5. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. (Gastroenterology)
  6. INCIDENCE OF HEPATOCELLULAR CARCINOMA AND ASSOCIATED RISK FACTORS IN HEPATITIS C-RELATED ADVANCED LIVER DISEASE (Gastroenterology)
  7. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
  8. The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (Hepatology)
  9. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. (Journal of Hepatology)
  10. Strategies for safer liver surgery and partial liver transplantation. (New England Journal of Medicine)

Their papers